Expansion of Cancer Risk Profile for <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variants
2022 · JAMA Oncology · 187 citations
https://doi.org/10.1001/jamaoncol.2022.0476
Y
Yuya Sekine
Akita University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
354
Citations
7
h-index
5
i10-index
Yuya Sekine is an academic researcher from Akita University. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Renal cell carcinoma treatment & Prostate Cancer Treatment and Research. The author has an h-index of 7, co-authored 53 publications.
Papers by this author
worksEffects of aging on complications following robot-assisted radical prostatectomy
2024 · International Journal of Clinical Oncology · 6 citations
https://doi.org/10.1007/s10147-024-02660-7
First-line axitinib therapy is less effective in metastatic renal cell carcinoma with spindle histology
2020 · Scientific Reports · 3 citations
https://doi.org/10.1038/s41598-020-77135-6
Efficacy of modified enfortumab vedotin ineligible criteria (mEVITA) in advanced urothelial carcinoma
2025 · Scientific Reports · 3 citations
https://doi.org/10.1038/s41598-025-09806-1
Real-world short-term outcomes and treatment regimen comparisons in patients with metastatic renal cell carcinoma treated with first-line immune combinations
2025 · BMC Cancer · 2 citations
https://doi.org/10.1186/s12885-025-13504-6
Impact of aspirin on biochemical recurrence of prostate cancer after robot assisted radical prostatectomy in a multicenter retrospective cohort study
2025 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-025-86521-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat